Home › Medidata's Risk-Based Monitoring Solution Selected By Infinity Pharmaceuticals To Advance Oncology Research
 

Keywords :   


Medidata's Risk-Based Monitoring Solution Selected By Infinity Pharmaceuticals To Advance Oncology Research

2015-11-25 01:19:03| drugdiscoveryonline Home Page

Medidata, the leading global provider of cloud-based solutions for clinical research in life sciences, recently announced that Infinity Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the discovery, development and delivery of medicines for difficult-totreat diseases, has expanded its use of the Medidata Clinical Cloud.

Tags: research selected solution advance

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.05Feedlot inventories below last year
29.05Ex-FTX executive sentenced to over 7 years in prison
29.05Insulation scandal: I have to scrape mould off the walls every two weeks'
29.05Eastern North Pacific Tropical Weather Outlook
29.05Atlantic Tropical Weather Outlook
29.05PM pledges to swap 'rip-off' degrees for apprenticeships
28.05Central Stockyards adds team members, prepares for Canadian expansion
28.05Life happens for us, not to us
More »